Division of Gastroenterology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 33303, Taiwan.
Division of Infectious Disease, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 33303, Taiwan.
Nutrients. 2019 May 23;11(5):1150. doi: 10.3390/nu11051150.
Acute diarrhea is a major cause of childhood morbidity and an economic burden for families. The aim of this study is to explore the effect of probiotics on clinical symptoms, intestinal microbiota, and inflammatory markers during childhood diarrhea.
Children ( = 81) aged six months to six years (mean age 2.31 years) hospitalized for acute diarrhea were randomized to receive probiotics ( variety ; = 42) or no probiotics ( = 39) orally twice daily for seven days. Feces samples were also collected to evaluate microbial content using a traditional agar plate and next-generation sequencing. Immunoglobulin A (IgA), lactoferrin, and calprotectin were determined by enzyme-linked immunosorbent assay (ELISA) and compared in different groups. Other clinical symptoms or signs, including fever, vomiting, diarrhea, abdominal pain, bloated abdomen, daily intake, appetite, and body weight were also assessed.
Data were collected from 81 individuals across three different time points. Total fecal IgA levels in fecal extracts of the probiotics group were higher than those in the control group, reaching statistical significance ( 0.05). Concentrations of fecal lactoferrin and calprotectin were significantly downregulated in patients with probiotic variety (Lc) consumption compared to those of the control ( 0.05). Probiotic Lc administration may be beneficial for gut-microbiota modulation, as shown by the data collected at one week after enrollment. Counts of and species were elevated in stool culture of the probiotic group. Appetite and oral intake, body-weight gain, abdominal pain, bloating, as well as bowel habits (diarrhea) were much better in children receiving probiotics compared with those in the control group.
Fecal IgA increased during acute diarrhea under Lc treatment; in contrast, fecal lactoferrin and calprotectin were downregulated during acute diarrhea under Lc treatment. Probiotic Lc may be a useful supplement for application in children during acute diarrhea to reduce clinical severity and intestinal inflammatory reaction.
急性腹泻是儿童发病和家庭经济负担的主要原因。本研究旨在探讨益生菌对儿童腹泻期间临床症状、肠道微生物群和炎症标志物的影响。
将 81 名 6 个月至 6 岁(平均年龄 2.31 岁)的急性腹泻住院儿童随机分为口服益生菌(品种)组(42 名)或非益生菌(39 名)组,每天两次,共 7 天。还采集粪便样本,使用传统琼脂平板和下一代测序评估微生物含量。通过酶联免疫吸附试验(ELISA)测定免疫球蛋白 A(IgA)、乳铁蛋白和钙卫蛋白,并比较不同组之间的差异。还评估了其他临床症状或体征,包括发热、呕吐、腹泻、腹痛、腹胀、日常摄入量、食欲和体重。
从三个不同时间点共收集了 81 名个体的数据。益生菌组粪便提取物中的总粪便 IgA 水平高于对照组,达到统计学意义( 0.05)。与对照组相比,益生菌 Lc 组的粪便乳铁蛋白和钙卫蛋白浓度显著下调( 0.05)。与对照组相比,益生菌 Lc 组 (和 )的定植计数升高。与对照组相比,接受益生菌治疗的儿童的食欲和口服摄入量、体重增加、腹痛、腹胀以及肠道习惯(腹泻)均有明显改善。
在 Lc 治疗下急性腹泻时粪便 IgA 增加;相反,在 Lc 治疗下急性腹泻时粪便乳铁蛋白和钙卫蛋白下调。益生菌 Lc 可能是儿童急性腹泻的一种有用补充,可减轻临床严重程度和肠道炎症反应。